Durable responses at ≥12 months with zola-cel in severe refractory systemic lupus erythematosus: safety, efficacy, and translational findings from the full phase 1 Breakfree-1 cohort
File
More Virtual Posters

If you are a health practitioner, you may Login/Register to comment.
Due to the nature of these comment forums, only health practitioners are allowed to comment at this time.